You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (ii) Distribution of new outpatient clients by primary drug for each age group

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Age known	Age not known
Opiates	9.8	23.2	39.8	39.8	41.8	38.5	42.4	24.0	27.4	30.1
Cocaine	12.2	26.3	37.9	43.9	42.9	47.3	37.4	31.3	29.5	23.6
Stimulants	6.7	11.0	6.6	4.7	3.0	2.8	1.3	1.0	8.2	6.3
Hypnotics and sedatives	0.9	1.1	1.6	2.8	5.5	6.3	10.3	36.3	2.0	1.6
Hallucinogens	1.3	1.8	1.1	0.4	0.3	0.1	0.6	0.1	1.3	1.0
Volatile substances	1.1	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1
Cannabis	67.2	35.4	12.3	7.6	5.5	4.9	4.4	4.9	30.4	35.8
Other substances	0.8	1.0	0.7	0.8	1.0	0.2	3.6	2.1	0.9	1.5
Total	11604	36413	15824	6606	3358	1823	906	699	77233	24385

Notes:

Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, MT, NL, SK, FI, SE

Last data available from Spain refer to 2004.

The number of treatment clients in each country is listed in [Table TDI-7].

See also ''TDI-106-New outpatient age at first use and primary drug.xls'' on distribution by country and ''General notes for interpreting data'' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI outpatient treatment centres.